Search COVID-19

Information about the TGA's safety monitoring of COVID-19 vaccines.

TGA, part of the Department of Health, has granted a second provisional determination to Biocelect Pty Ltd (on behalf of Novavax Inc.) in relation to its COVID-19 vaccine, Nuvaxovid.

The TGA has issued an infringement notice of $13,320 to Getafix Café Pty Ltd (the company) for an alleged breach of the Therapeutic Goods Act 1989 in relation to the advertising of a COVID-19 rapid antigen test on its website.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA is urging consumers to only purchase COVID-19 rapid antigen tests (RATs) that are approved for use in Australia to avoid the risk of poor test performance that could arise from using unapproved, repackaged or repurposed RATs.

Consumers are advised to be cautious about ivermectin products that are sold by unverified online stores.

The TGA has issued an infringement notice for $2,664 to an individual for a NSW based herbal medicine practitioner for an alleged breach of the Advertising Code.

The TGA has granted provisional approval to AstraZeneca Pty Ltd for its tixagevimab and cilgavimab (EVUSHELD) for the prevention of COVID-19 in people who are at risk of infection but have not been exposed to the virus, known as pre-exposure prevention of COVID-19.

Information about the TGA's safety monitoring of COVID-19 vaccines.

The TGA has provisionally approved the Moderna CoVID-19 vaccine, SPIKEVAX, for use in individuals 6 years and older.